A key immune evasion mechanism in ccRCC is the upregulation of immune checkpoint molecules such as PD-1, PD-L1 (its ligand), and CTLA-4, which suppress T cell activity and contribute to T cell exhaustion [22]. The gene discussed is CTLA4; the disease is nonpapillary renal cell carcinoma.